MAPT and Alzheimer disease: Given the role of GAP-43 in synaptic remodeling and activity and the consistent finding of increased levels of CSF GAP-43 in AD, we hypothesize that elevated GAP-43 and associated synaptic changes may be linked to facilitated trans-synaptic spread of tau pathology in AD.